Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | AZNAstraZeneca PLC | JNJJohnson & Johnson |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United Kingdom | United States |
| Market cap | $290B | $676B |
| Price | $186.76 | $280.78 |
| Last day | −1.39% | −0.47% |
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN analysis and Q-Scores →Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.
JNJ analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.